| Literature DB >> 30071061 |
Ming Hu1,2, Xintai Zhong3, Xuejiang Cui2, Xun Xu2, Zhanying Zhang2, Lixian Guan2, Quanyao Feng2, Yiheng Huang2, Weilie Hu1.
Abstract
OBJECTIVES: To develop and validate an individualized nomogram to predict probability of patients with ureteral calculi developing into urosepsis.Entities:
Mesh:
Year: 2018 PMID: 30071061 PMCID: PMC6072035 DOI: 10.1371/journal.pone.0201515
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of the development group and validation group.
| Development group(n = 747) | Validation group | Z/χ2 | P Value | |
|---|---|---|---|---|
| Gender (%) | 0.912 | 0.346 | ||
| Male | 422(56.5) | 169(53.3) | ||
| Female | 325(43.5) | 148(46.7) | ||
| Age, year | 53(43~63) | 52(43~64) | 0.298 | 0.765 |
| Diabetes (%) | ||||
| No | 677(90.6) | 281(88.6) | 0.978 | 0.323 |
| Yes | 70(9.4) | 36(11.4) | ||
| Hypertension (%) | ||||
| No | 567(75.9) | 225(71.0) | 2.838 | 0.105 |
| Yes | 180(24.1) | 92(29.0) | ||
| Previous surgery of calculi (%) | 0.591 | 0.472 | ||
| No | 573(76.7) | 250(78.9) | ||
| Yes | 174(23.3) | 67(21.1) | ||
| Functional solitary kidney (%) | ||||
| No | 691(92.5) | 292(92.1) | 0.048 | 0.802 |
| Yes | 56(7.5) | 25(7.9) | ||
| Maximum diameter of calculi, mm | 10(7~14) | 10(6–14) | 0.092 | 0.927 |
| Minimum diameter of calculi, mm | 6(5~8) | 6(4~8) | 1.002 | 0.316 |
| Mean CT attenuation value of calculi, Hu | 0.715 | 0.699 | ||
| <500 | 441(59.0) | 195(61.5) | ||
| 500~1000 | 251(33.6) | 102(32.2) | ||
| >1000 | 55(7.4) | 20(6.3) | ||
| Laterality of calculi (%) | 0.569 | 0.461 | ||
| Left | 377(50.5) | 168(53.0) | ||
| Right | 370(49.5) | 149(47.0) | ||
| Location of calculi (%) | 1.850 | 0.397 | ||
| Upper | 382(51.2) | 162(51.1) | ||
| Middle | 116(15.5) | 40(12.6) | ||
| Lower | 249(33.3) | 115(36.3) | ||
| Ipsilateral renal calculi (%) | 2.490 | 0.119 | ||
| No | 442(59.2) | 171(53.9) | ||
| Yes | 305(40.8) | 146(46.1) | ||
| Mean CT attenuation value of hydronephrosis, Hu | 2.127 | 0.345 | ||
| <8 | 573(76.7) | 231(72.9) | ||
| 8~16 | 132(17.7) | 68(21.4) | ||
| >16 | 42(5.6) | 18(5.7) | ||
| Degree of hydronephrosis (%) | 3.769 | 0.152 | ||
| Mild | 454(60.8) | 173(54.6) | ||
| Moderate | 164(22.0) | 84(26.5) | ||
| Severe | 129(17.2) | 60(18.9) | ||
| Urine WBC count (%) | 0.761 | 0.859 | ||
| No | 384(51.4) | 155(48.9) | ||
| Weakly positive | 184(24.6) | 81(25.6) | ||
| Moderately positive | 100(13.4) | 43(13.6) | ||
| Strongly positive | 79(10.6) | 38(12.0) | ||
| Urine nitrite (%) | 0.191 | 0.669 | ||
| No | 705(94.4) | 297(93.7) | ||
| Yes | 42(5.6) | 20(6.3) |
CT, computer tomography; WBC, white blood cells.
Univariate and multivariate logistic regression models in the development group.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| OR (95%CI) | P value | OR (95%CI) | P value | |
| Gender | 4.59(2.52~8.37) | <0.001 | 4.54(2.14~9.62) | <0.001 |
| Age, years | 1.05(1.03~1.08) | <0.001 | NA | |
| Diabetes | 2.25(1.11~4.45) | 0.024 | NA | |
| Hypertension | 2.14(1.25~3.68) | 0.006 | NA | |
| Functional solitary kidney | 4.47(2.28~8.75) | <0.001 | 3.02(1.28~7.14) | 0.012 |
| Previous surgery of calculi | 2.43(1.42~4.17) | 0.001 | NA | |
| Length of calculi size(mm) | 1.07(1.03~1.11) | <0.001 | NA | |
| Width of calculi size(mm) | 1.11(1.04~1.18) | 0.002 | NA | |
| Mean CT attenuation value of calculi (HU) | 1.00(1.00~1.00) | 0.001 | NA | |
| Laterality of calculi | 1.25(0.74~2.10) | 0.408 | NA | |
| Location of calculi | 0.69(0.50~0.95) | 0.021 | NA | |
| Ipsilateral renal calculi | 3.37(1.94~5.87) | <0.001 | NA | |
| Mean CT attenuation value of hydronephrosis (HU) | 2.61(1.83~3.73) | <0.001 | 3.17(2.00~5.04) | <0.001 |
| Degree of hydronephrosis | 1.22(0.89~1.68) | 0.222 | NA | |
| Urine WBC count | 3.69(2.78~4.90) | <0.001 | 2.94(2.14~4.03) | <0.001 |
| Urine nitrite | 10.77(5.55~20.90) | <0.001 | 4.71(2.08~10.69) | <0.001 |
OR, odds ratio; CI, confidence interval; NA, not available; HU, Hounsfield unit.
Fig 1Nomogram to predict the probability of urosepsis in the patient with ureteral calculi.
Fig 2Example prediction nomogram for risk of urosepsis in a patient with ureteral calculi.
The AUCs of the ROC curves for the nomogram and variables from the logistic regression model in the development group and validation group.
| Development group | Validation group | |||||
|---|---|---|---|---|---|---|
| AUC | 95%CI | P value | AUC | 95%CI | P value | |
| Nomogram variable | 0.914 | 0.88~0.95 | <0.001 | 0.874 | 0.80~0.95 | <0.001 |
| Gender | 0.676 | 0.61~0.74 | <0.001 | NA | ||
| Functional solitary kidney | 0.582 | 0.50~0.66 | 0.032 | NA | ||
| Mean CT attenuation value of hydronephrosis | 0.647 | 0.57~0.73 | <0.001 | NA | ||
| Urine WBC count | 0.863 | 0.82~0.90 | <0.001 | NA | ||
| Urine nitrite | 0.634 | 0.55~0.72 | <0.001 | NA | ||
ROC, receiver operating characteristic; AUC, area under the curve; CI, confidence interval.
Fig 3ROC curves for validating the discrimination power of the nomogram.
(A) Development group. (B) Validation group. (AUC = 0.914 vs. 0.874).
Fig 4Calibration plots of the nomogram for the probability of urosepsis patients with ureteral calculi in the development group and validation group.